The assistant professor of neurology at the University of Virginia spoke at the 2022 American Epilepsy Society Annual Meeting about clinical outcomes of patients with dementia who experience seizures.
This video originally appeared on NeurologyLive. The summary below has been lightly edited.
Recent research has proven a strong association between seizures and dementia, as findings have shown the high impact seizures have on clinical and mortality outcomes. As patients with epilepsy experience symptoms of cognitive decline, patients with dementia are similarly at a high risk of developing seizures. In addition, seizures have been often associated with more severe cognitive impairment among patients with dementia.
Recently, Ifrah Zawar, MD, presented an abstract on the clinical outcomes of patients who experience both seizures and dementia during a poster session at the 2022 American Epilepsy Society Annual Meeting, held December 2-6, in Nashville, Tennessee. In her presentation, she provided an overview of the study, in which results demonstrated that patients with active seizures and dementia at a younger age have worse cognition, poorer function, and higher mortality rates compared with patients who have dementia without seizures.
At the meeting, Zawar, assistant professor of neurology at the University of Virginia, sat down with NeurologyLive® for an interview and offered a summary about the current knowns and unknowns about epilepsy and seizures in those with dementia. She also explained the most important aspect of care and the most recent advances of care for patients in this specific population. Zawar provided detail on the previous research that has revealed the knowledge gaps between epilepsy and dementia.
Reference
Zawar I. Seizures in dementia associated with worse clinical outcomes, higher mortality rates and shorter lifespan. Presented at: AES Annual Meeting; December 2-6, 2022; Nashville, TN, and virtual.
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More